General Updates

MANUFACTURER OF $a(¢y BULK DRUGS & ' IMPORTERS OF DRUGS & PHARMACEUTICALSLTD. ~ SOLVENTS & CHEMICALS H.0: 203/4 SAHAKAR BHAVAN, 340/48 N.N STREET, MUMBAI-400009 ® : (022) 23455543 Email: corporate@aareydrugs.com REGD OFF. & FACTORY: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE ® (02525) 271049 Email: info@aareydrugs.com CIN:L99999MHI1990PLC056538 Date:- 11" September, 2026 BSE Limited National Stock Exchange of India Limited The Manager, Exchange Plaza Corporate Service Department BandraKurla Complex, P.J. Towers, Dalal Street, Bandra (E), Mumbai40-0 001 Mumb- 4a000i51 Scrip Code: 524412 NSE Symbol: AAREYDRUGS closure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, In terms of the requirements of Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has issued letters to those Shareholder’s whose email addresses are not registered with the Company/Depository Participants, providing the web link from where the Integrated Annual Report can be accessed on the Company’s website. The letter in this regard is enclosed herewith. You are requested to kindly take the above information record. Thanking You, Yours faithfully, For Aarey Drugs & Pharmaceuticals Limited Nha to (s Nimit Ghatalia Director DIN: 07069841 Encl.: a/a Hore CIN: CIN:' LDR 9U 9G 9S & 9P MHA HR 1M 9AC 9E 0U PTI LC CA 0LS 5 6LT5D.3 8 Registered office: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE Website: www.aareydrugs.com; Emal fo@aareydrugs.com Tel: (02525) 271049 Ref.No. Date 8™ September, 2026 FolioNo./DP-CLID Dear Shareholder, Sub.: Notice of 36" Annual General Meeting (AGM) of Aarey Drugs & Pharmaceuticals Ltd and Annual Report for Financial Year 2025-26. We are pleased to inform you that the 36" Annual General Meeting ("AGM') of the members of Aarey Drugs & Pharmaceuticals Ltd (‘the Company’) is scheduled to be held on Wednesday, 30" September, 2026 at 03.00 P.M (IST) through Video Conferencing ('vC') facility / Other Audio Visual Means ('OAVM'). As per Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the web- link, including the exact path, where complete details of the Annual Report are available is required to be sent to those member(s)who have not registered their email address(es) either with the Company or with any Depository or MUFG Intime India Private Limited (formerly Link Intime India Private Limited), Registrar to an Issue & Share Transfer Agent (RTA) of the Company. Accordingly, the web-link, including the exact path where complete details of the Annual Report for Financial Year 2025-26 are available at: Website : http://www.aareydrugs.com/ Exact path of Annual Report 2025-26 : http://www.aareydrugs.com/investors.html This letter is being sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or RTA of the Company as on the cut-off date as on Friday, 04™ September, 2026. Should you have any queries, please feel free to contact our investor relations department at investorgrievance@aareydrugs.com or 02239829999. Moreover, you are also requested to update your email address at the earliest either through your depository participants for electronic holding or send a communication to us / our RTA to facilitate the updation to continue receiving all important information & documents thereafter and encourage Green Initiative. Thanking you, Yoursfaithfully For Aarey Drugs & Pharmaceuticals Ltd sd/- Mr. Kailash Chand Jethlia Company Secretary & Compliance Officer